AIM
EW icon

Artemis Investment Management’s Edwards Lifesciences EW Stock Holding History

Artemis Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-54,457
Closed -$6.41M – 257
2022
Q1 		$6.41M Sell
54,457
-12,186
-18% -$1.37M 0.05% 207
2021
Q4 		$8.63M Buy
+66,643
New +$7.77M 0.06% 197
2020
Q4 		– Sell
-213,322
Closed -$17M – 269
2020
Q3 		$17M Buy
213,322
+127,018
+147% +$9.91M 0.21% 135
2020
Q2 		$5.97M Sell
86,304
-2,943
-3% -$209K 0.08% 203
2020
Q1 		$5.62K Buy
89,247
+18
+0% +$1.3K 0.01% 166
2019
Q4 		$6.93M Sell
89,229
-7,677
-8% -$599K 0.09% 184
2019
Q3 		$7.09M Sell
96,906
-27,189
-22% -$1.91M 0.1% 193
2019
Q2 		$7.65M Sell
124,095
-82,320
-40% -$4.98M 0.09% 207
2019
Q1 		$13.2M Sell
206,415
-92,631
-31% -$5.29M 0.15% 173
2018
Q4 		$15.3M Buy
+299,046
New +$15.1M 0.2% 138

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artemis Investment Management's EW Position: Q2 2022 in Review

Artemis Investment Management sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 54,457 shares — an estimated $6.41M sold.

Artemis Investment Management first reported a position in EW in Q4 2018 and held it in 10 quarters. The position peaked at $17M in Q3 2020. 1,272 funds tracked by Wall St. Rank hold EW as of Q2 2022.

  • Artemis Investment Management reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
  • Artemis Investment Management sold 54,457 Edwards Lifesciences shares in Q2 2022, an estimated $6.41M.
  • Artemis Investment Management first reported a position in Edwards Lifesciences in Q4 2018 and held it in 10 quarters.
  • Artemis Investment Management's Edwards Lifesciences position peaked at $17M in Q3 2020.
  • 1,272 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on Artemis Investment Management's 13F filing for Q2 2022, filed 22 Jul 2022.